Coriolus-MRL Supplementation in Patients Infected with Low-Risk and High-Risk HPV subtypes-Bulgarian experience
Prof. Todor Chernev 1
This poster was presented at the 3rd Congress of Gynecologists and obstetricians of Macedonia (with International Participation) from May 16th to 19th, 2013, Orhid, Macedonia.
Conclusion: Coriolus-MRL has no adverse reactions and drug interactions with the main drugs used for the treatment and it could be taken during pregnancy. It is an addition to the methods for prevention and treatment (both combined and conservative) of HPV infection.
1 University Hospital of Obstetrics and Gynecology-Sofia, Bulgaria.